Nautilus Biotechnology

$4.33 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Nautilus Biotechnology

Nautilus Biotechnology, Inc. operates as a life sciences company. The Company develops a proteomics platform to enable fundamental advancements across biomedical research and drug discovery. Nautilus Biotechnology focuses on patients and healthcare professionals worldwide.

Stock Analysis

last close $3.97
1-mo return -24.7%
3-mo return -27%
avg daily vol. 404.05T
52-week high 25.89
52-week low 3.94
market cap. $493M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. 47.4%

Subscribe now for daily local and international financial news